Quick Answer
ROCKWELL MEDICAL, INC. reported Cash and Equivalents of $10.71 million for fiscal year 2025.
ROCKWELL MEDICAL, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $10.71M | -31.6% |
| 2024 | $15.66M | +74.4% |
| 2023 | $8.98M | -11.1% |
| 2022 | $10.10M | -23.9% |
| 2021 | $13.28M | -72.7% |
| 2020 | $48.68M | +312.7% |
| 2019 | $11.79M | -48.1% |
| 2018 | $22.71M | +170.2% |
| 2017 | $8.41M | -51.1% |
| 2016 | $17.18M | -44.9% |
| 2015 | $31.20M | -52.6% |
| 2014 | $65.80M | +453.8% |
| 2013 | $11.88M | +152.2% |
| 2012 | $4.71M | -17.6% |
| 2011 | $5.72M | -53.4% |
| 2010 | $12.26M | -46.8% |
| 2009 | $23.04M | +311.6% |
| 2008 | $5.60M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.61M | +10.3% | +9.0% |
| June 30, 2025 | $12.48M | +5.2% | +9.6% |
| March 31, 2025 | $11.39M | +71.5% | -27.3% |
| December 31, 2024 | $15.66M | +74.4% | +26.9% |
| September 30, 2024 | $12.34M | +59.0% | +4.0% |
| June 30, 2024 | $11.86M | +32.4% | +78.6% |
| March 31, 2024 | $6.64M | -39.0% | -26.1% |
| December 31, 2023 | $8.98M | -11.1% | +15.8% |
- ROCKWELL MEDICAL, INC. showed a decrease of -31.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, ROCKWELL MEDICAL, INC.’s cash and equivalents has grown by 91.4% (from $5.60 million to $10.71 million).
- The most recent figure is from ROCKWELL MEDICAL, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: